Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
NCT06584084

Technical and Clinical Validation of the WPM-SEMG Prototype

Led by Alain Kaelin · Updated on 2024-09-19

70

Participants Needed

1

Research Sites

431 weeks

Total Duration

On this page

Sponsors

A

Alain Kaelin

Lead Sponsor

U

University of Applied Sciences and Arts of Southern Switzerland

Collaborating Sponsor

AI-Summary

What this Trial Is About

Validation study designed to demonstrate the technical and clinical performance, and the safety of a new medical device in healthy volunteers and patients with myopathy or neuropathy. The medical device is the WPM-SEMG prototype designed for recording electrophysiological signals of muscles.

CONDITIONS

Official Title

Technical and Clinical Validation of the WPM-SEMG Prototype

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Healthy volunteers
  • Female or male
  • 18 years or older
  • Preserved cognitive capacity
  • Ability to understand the study
  • Willingness to complete all the study assessments
  • No chronic or concomitant use of medications or treatment
  • Written informed consent
  • Patients with diagnosis of myopathy or neuropathy requiring needle-EMG testing
  • No chronic or concomitant use of medications or treatment that may influence the measure in the opinion of the investigator (e.g., muscle relaxants, statin, benzodiazepine)
Not Eligible

You will not qualify if you...

  • Skin lesions in the area below the electrode
  • Allergy to metal alloys
  • History of skin disease
  • Pregnancy
  • Lactation
  • Known causes of neuromuscular disease (for healthy volunteers)
  • Cognitive and/or psychiatric disorders (for patients)
  • Neuromuscular disease other than myopathy and neuropathy (for patients)
  • Inability to follow the procedures of the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Neurocentro della Svizzera Italiana

Lugano, Switzerland, 6900

Actively Recruiting

Loading map...

Research Team

A

Alain Kaelin, Prof.

CONTACT

M

Manuela Maffongelli

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here